Shopping Cart 0
Cart Subtotal
USD 0

West Pharmaceutical Services Inc (WST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

West Pharmaceutical Services Inc (West Pharmaceutical) manufactures components and delivery systems for injectable drugs and healthcare products. The company's major products include primary packaging, containment solutions, cartridge systems and components, prefillable systems, reconstitution and transfer systems, drug delivery systems and specialty components, among others. It also offers contract manufacturing and analytical lab services. West Pharmaceutical serves biologic, generic, pharmaceutical, diagnostic, and medical device companies across the world. The company distributes its products and services directly and also through a network of distributors worldwide. It has presence in North and South America, Europe, Asia and Australia. West Pharmaceutical is headquartered in Exton, Pennsylvania, the US.

West Pharmaceutical Services Inc (WST)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

West Pharmaceutical Services Inc, Medical Devices Deals, 2012 to YTD 2018 8

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deal Details 10

Licensing Agreements 10

West Pharma Enters into Licensing Agreement with Mallinckrodt 10

Debt Offering 11

West Pharma Completes Private Placement Of 3.67% Series A Senior Notes Due 2022 For USD 42 Million 11

West Pharma Completes Private Placement Of Series C Senior Notes Due 2027 For USD 73 Million 12

West Pharma Completes Private Placement Of 3.82% Series B Senior Notes Due 2024 For USD 53 Million 13

West Pharmaceutical Services Inc-Key Competitors 14

West Pharmaceutical Services Inc-Key Employees 15

West Pharmaceutical Services Inc-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Recent Developments 18

Financial Announcements 18

Jul 26, 2018: West announces second-quarter 2018 results 18

Apr 26, 2018: West Announces First-Quarter 2018 Results 20

Feb 15, 2018: West Announces Fourth-Quarter and Full-Year 2017 Results and Announces Quarterly Dividend 22

Oct 26, 2017: West Announces Third-Quarter 2017 Results 24

Jul 27, 2017: West Announces Second-Quarter 2017 Results 26

Apr 27, 2017: West Announces First-Quarter 2017 Results 28

Feb 16, 2017: West Announces Fourth-Quarter and Full-Year 2016 Results and Announces Quarterly Dividend 30

Corporate Communications 33

Jun 21, 2018: West Pharmaceutical Services names Bernard Birkett As Chief Financial Officer 33

Mar 02, 2018: West Chief Financial Officer William Federici Announces Plans to Retire 34

Feb 26, 2018: West Names Silji Abraham Chief Digital And Transformation Officer 35

Jun 01, 2017: West Elects New Director to the Board 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37


List Of Figure

List of Figures

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

West Pharmaceutical Services Inc, Medical Devices Deals, 2012 to YTD 2018 8


List Of Table

List of Tables

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

West Pharmaceutical Services Inc, Medical Devices Deals, 2012 to YTD 2018 8

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

West Pharma Enters into Licensing Agreement with Mallinckrodt 10

West Pharma Completes Private Placement Of 3.67% Series A Senior Notes Due 2022 For USD 42 Million 11

West Pharma Completes Private Placement Of Series C Senior Notes Due 2027 For USD 73 Million 12

West Pharma Completes Private Placement Of 3.82% Series B Senior Notes Due 2024 For USD 53 Million 13

West Pharmaceutical Services Inc, Key Competitors 14

West Pharmaceutical Services Inc, Key Employees 15

West Pharmaceutical Services Inc, Subsidiaries 16

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

West Pharmaceutical Services Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

West Pharmaceutical Services Inc (West Pharmaceutical) manufactures components and delivery systems for injectable drugs and healthcare products. The company's major products include primary packaging, containment solutions, cartridge systems and components, prefillable systems, reconstitution and transfer systems, drug delivery systems and specialty components, among others. It also offers contract manufacturing and analytical lab services. West Pharmaceutical serves biologic, generic, pharmaceutical, diagnostic, and medical device companies across the world. The company distributes its products and services directly and also through a network of distributors worldwide. It has presence in North and South America, Europe, Asia and Australia. West Pharmaceutical is headquartered in Exton, Pennsylvania, the US.

West Pharmaceutical Services Inc (WST)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

West Pharmaceutical Services Inc, Medical Devices Deals, 2012 to YTD 2018 8

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deal Details 10

Licensing Agreements 10

West Pharma Enters into Licensing Agreement with Mallinckrodt 10

Debt Offering 11

West Pharma Completes Private Placement Of 3.67% Series A Senior Notes Due 2022 For USD 42 Million 11

West Pharma Completes Private Placement Of Series C Senior Notes Due 2027 For USD 73 Million 12

West Pharma Completes Private Placement Of 3.82% Series B Senior Notes Due 2024 For USD 53 Million 13

West Pharmaceutical Services Inc-Key Competitors 14

West Pharmaceutical Services Inc-Key Employees 15

West Pharmaceutical Services Inc-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Recent Developments 18

Financial Announcements 18

Jul 26, 2018: West announces second-quarter 2018 results 18

Apr 26, 2018: West Announces First-Quarter 2018 Results 20

Feb 15, 2018: West Announces Fourth-Quarter and Full-Year 2017 Results and Announces Quarterly Dividend 22

Oct 26, 2017: West Announces Third-Quarter 2017 Results 24

Jul 27, 2017: West Announces Second-Quarter 2017 Results 26

Apr 27, 2017: West Announces First-Quarter 2017 Results 28

Feb 16, 2017: West Announces Fourth-Quarter and Full-Year 2016 Results and Announces Quarterly Dividend 30

Corporate Communications 33

Jun 21, 2018: West Pharmaceutical Services names Bernard Birkett As Chief Financial Officer 33

Mar 02, 2018: West Chief Financial Officer William Federici Announces Plans to Retire 34

Feb 26, 2018: West Names Silji Abraham Chief Digital And Transformation Officer 35

Jun 01, 2017: West Elects New Director to the Board 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37


List Of Figure

List of Figures

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

West Pharmaceutical Services Inc, Medical Devices Deals, 2012 to YTD 2018 8


List Of Table

List of Tables

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

West Pharmaceutical Services Inc, Medical Devices Deals, 2012 to YTD 2018 8

West Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

West Pharma Enters into Licensing Agreement with Mallinckrodt 10

West Pharma Completes Private Placement Of 3.67% Series A Senior Notes Due 2022 For USD 42 Million 11

West Pharma Completes Private Placement Of Series C Senior Notes Due 2027 For USD 73 Million 12

West Pharma Completes Private Placement Of 3.82% Series B Senior Notes Due 2024 For USD 53 Million 13

West Pharmaceutical Services Inc, Key Competitors 14

West Pharmaceutical Services Inc, Key Employees 15

West Pharmaceutical Services Inc, Subsidiaries 16

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

West Pharmaceutical Services Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.